Continued studies will deepen scientists’ understanding of virus-host interactions at the molecular level and also pave the way for developing better drugs to fight emerging viruses.
Scientists map how transitions from day to night control gene regulatory networks in cyanobacteria, revealing key orchestrators of metabolic switching.
Scientists developed a process (or pipeline) that combined molecular probes—a specific chemical that binds to microbes carrying out a particular function—with a method that isolated these cells from their complex community.
Scientists screen for nanobodies that recognize wild type and mutant functional proteins to develop a framework to disrupt protein interactions that can cause disease.
A comprehensive literature review linking algae and antivirals determines compounds in algae may demonstrate an exceptional—and as yet untapped—potential to combat viral diseases at every point along the viral infection pathway.
PNNL teamed with academia and industry to develop a novel zero-emission methane pyrolysis process that produces both hydrogen and high-value carbon solids suitable for an array of manufacturing applications.
PNNL’s newest solvent captures carbon dioxide from power plants for as little as $47.10 per metric ton, marking a significant milestone in the journey to lower the cost of carbon capture.